OGA, O-GlcNAcase, 10724

N. diseases: 140; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0542476
Disease: Forgetful
Forgetful
0.020 Biomarker phenotype BEFREE Here, we discuss the findings of that study and the development of OGA inhibitors as novel therapeutic strategy for treatment of age-related memory impairment in neurodegenerative diseases. 31668062 2019
CUI: C0542476
Disease: Forgetful
Forgetful
0.020 Biomarker phenotype BEFREE O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment. 22503002 2013